UK-based Futura Medical is moving ever closer to OTC approval in the US for its drug-free erectile dysfunction (ED) treatment MED3000.
Futura recently met with the US Food and Drug Administration for a pre-submission meeting to define and confirm the detail of the work required for OTC classification for MED3000 – a gel that works via a mixture of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?